Bradley Boyer, PA
Physician Assistant · Millville, DENPI 1548527245
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,687 of the $3,287 with a category attached, or 81.7%. It is spread thinly across 24 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,735 and has fallen 75.2% since, to $431 in 2025. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$600
- AstraZeneca$336
- Novo Nordisk$312
- Abbott$238
- Biohaven Pharmaceutical Holding Company Ltd.$221
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$60018%
- Food & beverage$2,68782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 1 | $600 |
| AstraZeneca | 14 | $336 |
| Novo Nordisk | 17 | $312 |
| Abbott | 15 | $238 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $221 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $215 |
| AbbVie | 6 | $214 |
| Scilex Pharmaceuticals Inc. | 11 | $211 |
| Collegium Pharmaceutical, Inc. | 14 | $184 |
| Biohaven Pharmaceuticals, Inc. | 14 | $115 |
| Amgen(2 entities) | 6 | $94 |
| Lilly USA, LLC | 5 | $88 |
| Redhill Biopharma Inc. | 6 | $86 |
| Medtronic | 4 | $77 |
| Exact Sciences | 3 | $68 |
| Pfizer | 3 | $58 |
| Vertos Medical, Inc. | 2 | $40 |
| Bayer | 1 | $25 |
| Gilead | 1 | $23 |
| Almatica Pharma LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $15 |
| Insulet Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BELBUCA$600
- UBRELVY$125
- NURTEC ODT$122
- FARXIGA$120
How this compares
$3,287 in reported general payments places this provider in the 90th percentile of 527 physician assistant providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 102 | $101,310 |
| OzempicSemaglutide | 94 | $96,656 |
| RybelsusSemaglutide | 16 | $23,430 |
| Rosuvastatin Calcium | 66 | $1,394 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $1,229 |
| Ezetimibe | 36 | $1,229 |
| Gabapentin | 55 | $907 |
| Atorvastatin Calcium | 103 | $881 |
| Tamsulosin Hcl | 57 | $862 |
| Olmesartan Medoxomil | 30 | $794 |
| Montelukast Sodium | 55 | $761 |
| Potassium Chloride | 20 | $733 |
| Metoprolol Succinate | 49 | $720 |
| Pantoprazole Sodium | 59 | $679 |
| Methylprednisolone | 84 | $672 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $312 | $120,087110 claims |
| Lilly USA, LLCMounjaro | $88 | $101,310102 claims |
| AbbVieSynthroid | $214 | $64114 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $30636 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 physician assistant providers in Delaware.
Other physician assistant in Millville
- Brianna BrancatoMillville$5K
- James LustDover$30K
- Jennifer RahnLewes$13K
- Drew VenablesLewes$12K
- Vi BanhNewark$12K
- Morgan PopovichLewes$12K
- Jason SaulWilmington$9K
- Alexandra KrochtaNewark$9K
- Paige VenablesMilford$8K
- Seth CallahanNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.